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The most elegant and compelling example of the symbiotic co-evolution between 
producer and consumer is the milk synthesised by a mammalian mother for her infant. 
Hinde and German (2012) 
 
 
 
Artificial feeding of infants is, in fact, the largest uncontrolled in vivo experiment in 
human history. Minchin (1989) 
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Abstract 
 
The focus of this body of research was to investigate the potential associations 
between breastfeeding and fatty acid deficiencies in Autism Spectrum Disorder 
(ASD). As research progressed, the mediational role of fatty acid deficiency in the 
relationship between breastfeeding duration and ASD diagnosis was examined.  
 
Breastmilk is a bioactive substance common to all mammals and consists of three 
stages: colostral milk, transitional milk and mature milk. One aim of this thesis is to 
reconceptualise colostrum as an ‘immunological and functional instruction manual’ 
rather than a source of nutrition for the neonate. It is accepted in animal research that 
colostrum assists with gut maturation and that a lack of colostral feeding affects the 
offspring’s immune function. Thus, a proposition of this thesis is that it is crucial that 
the baby receives colostrum as soon as possible after birth and that the absence of 
colostral feeding leaves a neonate critically exposed to environmental insult.  

This thesis investigates some of the currently accepted pre- and peri-natal risk factors 
for ASD and reconceptualises them as variables that may contribute to suboptimal 
breastfeeding; specifically, a lack of breastfeeding during the first hour after birth and 
a reduction in breastfeeding duration. 
 
Inspired by research linking breastfeeding and ASD, Paper 1 is a commentary 
focusing on fatty acid deficiencies in ASD as a potential result of a lack of 
breastfeeding. The animal research model is considered and the lack of first hour  
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breastfeeding data in any paper is noted. This paper also discusses the inconsistencies 
in regard to what is coded as breastfeeding in many research papers.  
 
Paper 2 is a review paper inspired by Horrobin’s  ‘Membrane phospholipid hypothesis 
of schizophrenia’. It takes the evidence that Horrobin presented for his hypothesis; 
that dysregulated fatty acid metabolism interrupts cell signalling, and investigates the 
possibility that the same or a similar mechanism could be operating in ASD.  
 
Paper 3 reports on the results of a pilot study conducted with parents of children with 
an ASD diagnosis. It investigates the utility of a clinical fatty acid deficiency scale 
that is non-invasive and reportable by parents. The paper focuses on first hour 
breastfeeding and controls for the effect of family grouping.   
 
Paper 4 reports on a large study investigating the link between pre-natal risk factors 
identified in the literature as associated with an ASD diagnosis, breastfeeding duration, 
fatty acid status and the potential for fatty acid status to be a mediating factor between 
breastfeeding duration and ASD diagnosis.  
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Chapter 1 – Autism Spectrum Disorder, fatty acids and colostrum 
 
 
Introduction – what is ASD? 
 
 
ASD is one of the 21st century’s biggest medical mysteries. Despite over 100 years of 
research, we are no closer to a definitive cause of autism. Parenting style, 
environmental toxins, genetics, testosterone and the pre- and post-natal environment 
have all been posited as causal agents, however there is still no clear etiology nor path 
to prevention or cure. With an estimated Autism diagnosis being given to a child 
approximately every 20 minutes, it has never been more crucial to find new avenues 
to explore.  
 
Autism Spectrum Disorder is a disorder usually diagnosed in childhood that is 
characterized by a continuum of social and communicative irregularities and deficits.  
In contrast to their normally developing peers, those diagnosed with a mild Autism 
Spectrum Disorder often respond inappropriately in conversations, may not maintain 
cultural norms regarding eye contact and can have difficulty developing friendships or 
show a reduced interest in being socially connected. Those with severe Autism 
Spectrum Disorder are sometimes entirely non-verbal, engage in repetitive behaviours, 
and show little or no interest in developing relationships with others.  
 
Recent changes in the Diagnostic and Statistical Manual of Mental Disorders, Fifth 
Edition (APA, DSM-5) mean that children previously diagnosed with Asperger’s 
Disorder, Childhood Disintegrative Disorder or Pervasive Developmental Disorder, 
are now to be diagnosed with Autism Spectrum Disorder or another DSM-5 diagnosis.  
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Health burden of ASD 
 
ASD is a catastrophic life-long condition in which the majority of diagnosed 
individuals are severely limited in their ability to engage in fundamental activities 
such as work and relationships, with many never able to function independently 
without ongoing physical, emotional and financial support (Austin and Shandley, 
2010). The burden that an ASD diagnosis places on families, health and educational 
systems and welfare agencies cannot be underestimated.  
 
ASD prevalence continues to rise, with a recent study by the Centre for Disease 
Control (CDC) estimating that as many as 1 in 88 children (1 in 54 males) have an 
ASD diagnosis, an increase of 23% in two years (Centers for Disease Control, 2014). 
ASD represents a significant public health concern and definitive understandings as to 
its causation, prevention, treatment and control remains elusive.  
 
Comorbidity  
 
For much of its history, ASD has been considered a discrete psychological disorder 
with treatment solely confined to the realm of behavioural interventions. The 
diagnostic criteria updated in the DSM-5 remain firmly rooted in the triad of social 
impairment, speech/communication deficits and repetitive behaviours and restricted 
interests – the hallmark of diagnostic criteria since Autism’s inclusion in the DSM-III 
in 1980.  However, studies have highlighted ASD’s high level of comorbidity with 
other neurodevelopmental disorders such as ADHD, dyslexia, dyspraxia and epilepsy 
(Richardson & Ross, 2000).  
 
Autism Spectrum Disorder, Essential Fatty Acids and Infant Feeding 


B

A conceptual framework presented by Walter Kaufmann at the 2012 Autism 
Consortium in regard to the DSM-5, includes an acknowledgement of the growing 
evidence of ASD’s biological underpinnings. Firstly, Kaufmann (2012) noted ASD’s 
comorbidity with ADHD, Social Anxiety and Intellectual Disability. Secondly, a suite 
of biological symptomatology known to be extremely common to those with ASD 
was referenced: Gastro-intestinal dysfunction, sleep disturbance, Motor problems, 
Epilepsy-EEG abnormalities and Immune dysfunction. Whilst certainly not the 
acknowledgement of ASD as the disease state that some researchers have called for 
(Shandley & Austin, 2010), this conceptualisation represents an acceptance of the 
growing evidence of biological disturbances in ASD.  
 
Genetics 

 
With emerging evidence of a familial association and the disproportionate number of 
boys than girls being diagnosed (4:1), researchers began envisaging a single gene 
explanation of ASD. The comorbidity of ASD with known genetic conditions such as 
Fragile X and Rett’s syndrome highlighted the potential of ASD to be genetically 
predetermined (Budimirovic & Kaufmann, 2011). However the percentage of these 
cases turned out to be small, accounting for only 6-15% of ASD cases (Rossignol & 
Frye, 2012) and thus far ASD research has not been able to unearth a single gene or 
chromosomal disorder that conclusively explains the development of ASD (Rossignol 
& Frye, 2012). Nevertheless, a promising avenue of research has identified specific 
genetic polymorphisms associated with both a reduction and increase in ASD risk. A 
recent meta-analysis of polymorphism studies found MTHFR gene polymorphisms 
associated with ASD; the C677T gene (particularly in a homozygotic configuration 
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TT or CC) was found to be associated with elevated ASD risk and the homozygotic 
A1298C gene was found to be protective (Pu, Shen & Wu, 2013).  
 
Environment 

 
Whilst historically biological research into ASD has focused on the brain as the 
potential location of pathology, there is more compelling evidence that ASD is a 
pathology of the whole body system that is influenced by an individual’s genetics and 
their idiosyncratic exposure to various environmental factors (Herbert, 2010).  
 
With the more compelling evidence for an underlying biological and/or environmental 
mechanism to exist, in addition to genetics, research has dispersed into five main 
areas of concern: immune dysregulation, inflammation, oxidative stress, 
mitochondrial dysfunction and exposure to environmental toxicants (Rossignol & 
Frye, 2012).  
 
In the last five years, the role of mitochondrial dysfunction in ASD has become a 
research focus and many researchers have proposed that ASD is a mitochondrial 
disorder (Clark-Taylor & Clark-Taylor, 2004). Recently, Rossignol & Frye (2012) 
stated that due to the mitochondria’s important role in lipid metabolism, this may 
explain the lipid abnormalities found in ASD.  
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Chapter 2: The intersection of genetics and environment: Phospholipids, fatty 
acids and metabolism   
 
 
Lipids 

 
Lipids are fatty acids and their derivatives, and substances related biosynthetically or 
functionally to these compounds. For many years lipids were considered only to be 
important as sources of energy and the building blocks of membranes. However, in 
recent times, virtually every lipid class has been found to have some unique biological 
role that is distinct from the above. 
 
Phospholipids are lipids that contain phosphor and are major structural components of 
neuronal cell membranes. They are comprised of a glycerol three-carbon atom 
backbone, with a phosphor in the third position and fatty acids of many different types 
attached to the first two carbons (Figure 1). The synthesis and breakdown of 
phospholipids are involved in the growth and restructuring of synaptic connections 
(Horrobin, 1998).  

 
Figure 1: Phospholipid structure 
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Fatty acids 


Fatty acids are comprised of an organic acid group known as carboxylic acid and a 
long chain (aliphatic) tail of carbon and hydrogen. The aliphatic tail of a fatty acid can 
lack double carbon bonds or contain up to six, and the number of double bonds 
determines the saturation of the fatty acid. Thus, an absence of carbon bonds allows 
the fatty acid to be saturated with hydrogen and creates a straight, inflexible structure 
(a saturated fatty acid) whilst one carbon bond creates a fatty acid which is curved 
(monosaturated) and multiple double bonds create flexible ‘U’ shaped structures 
known as Polyunsaturated Fatty Acids (PUFAs) (Figure 2). PUFAs are incorporated 
into the nerve cell membranes of the brain and retina and contribute to the functional 
maturation of the Central Nervous System (Alessandri et al., 2004). 
 

Figure 2: Saturated and unsaturated fatty acid structure 
 
Fatty acids are required for phospholipid metabolism and both saturated and 
monosaturated fatty acids can be synthesized within the body. However PUFAs are 
classed as Essential Fatty Acids (EFAs) because they cannot be synthesized by the 
body endogenously and must be provided by the diet (Vancassel et al., 2001b)  
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Fatty acid metabolism begins with two precursor fatty acids: Linoleic Acid [LA] (18:2 
n-6) an Omega-6 fatty acid, and alpha-Linolenic acid [ALA] (18:3 n-3) an Omega-3 
fatty acid. Fatty acid metabolism involves an elongation and de-saturation process 
which means that at each iteration, the aliphatic tail of the PUFAs become longer and 
collects more carbon double bonds thus becoming more unsaturated (Figure 3).  
 
 
Figure 3: Fatty acid metabolism pathway 
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The PUFAs with the most highly unsaturated tails are Eicosapentaenoic acid [EPA] 
(20:5, n-3), Docosapentaenoic acid [DPA] (22:5, n-3) and Docosahexaenoic acid 
[DHA] (22:6, n-3). EPA, DPA and DHA are known as Highly Unsaturated Fatty 
Acids (HUFAs) or Long Chain Polyunsaturated Fatty Acids (LCPUFAs).  
 
The brain phospholipids are exceptionally rich in HUFAs (Horrobin, 1998; Vancassel 
et al, 2001). In fact, a unique feature of neurons is the smaller amounts of the 
precursors LA and ALA and the higher amounts of their metabolites: AA and DHA 
(Horrobin, 1998; Bourre, 2007). AA and DHA account for 20% of the dry brain 
weight (Alessandri et al., 2004; Meguid, Atta, Gouda, & Khalil, 2008; Vancassel et al., 
2001a). 
 
Also present in phospholipids are DGLA(20:3, n-6), Adrenic Acid(22:5, n-6), 
EPA(20:5, n-3) and DPA(22:5, n-3) but they are not as prolific as AA and DHA 
(Horrobin, 1998; Bourre, 2007). DHA is known to be involved in cell signalling and 
cell proliferation (Salem, Litman, Kim, & Gawrisch, 2001) and has an important 
structural role in the brain (Richardson, 2001) whilst AA is crucial for brain growth. 
EPA is not know to have a structural role, but is considered vital for the regulation of 
brain function (Richardson, 2001).  
 
Since the discovery that AA is a precursor of prostaglandins that are involved in 
inflammation and other disease states, the metabolism of EFAs have been linked with 
visual acuity, neurodevelopment, ADHD, schizophrenia, depression and more 
recently, ASD.  
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Fatty acids in breastmilk  
 
The history of fatty acid research is inextricably linked to infant feeding. Early studies 
by Hansen (Hansen, Haggard, Boelsche, Adam, & Wiese, 1958) discovered that 
deficiencies in LA and AA were implicated in infant eczema due to the common 
practice of feeding infants skim milk and sugar as a human milk substitute. Until 
more sophisticated artificial milks were introduced, infantile eczema was a common 
medical problem in the 1940s and 1950s (Holman, 1998). It is now firmly established 
that eczema may result from abnormal fatty acid metabolism in regard to converting 
LA to GLA. GLA is implicated in production of PG1s which are anti-inflammatory 
and offer immune support and suppress inflammation that can come from an over 
abundance of PG2s.  
 
Human milk contains significant amounts of AA and DHA (Marszalek & Lodish, 
2005), However, until 2002, infant formulas used in the US contained considerable 
amounts of 18:2, n-6 and 18:3, n-3, but no AA or DHA (Voigt et al., 2001) and 
infants have limited capacity to convert LA to AA and LNA to DHA (Marszalek, 
2005). Infants are at risk of fatty acid deficiency if they do not have access to 
breastmilk or formula milk that is supplemented with LCPUFAs.  
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Chapter 3: ASD and infant feeding 
 
 
Suboptimal breastfeeding (such as delaying the initiation of breastfeeding, early 
weaning or formula supplementation) has previously been established as a risk factor 
for health conditions such as asthma and atopic dermatitis (van Odijk et al., 2003), 
atopy, diabetes mellitus and childhood obesity (E. E. Stevens, Patrick, & Pickler, 
2009).  
 
Over the last decade, suboptimal breastfeeding is gradually being recognised as an 
ASD environmental risk factor (Al-Farsi et al., 2012; C. M. Brown, D. W. Austin, & 
L. Busija, 2014; Schultz et al., 2006; Tanoue & Oda, 1989).  Following the finding 
that children with ASD were more likely to have been weaned within one week of the 
instigation of breastfeeding (Tanoue & Oda), 1989), Schultz et al. (2006) surveyed 
861 parents of children with ASD and 123 parents of children without ASD, and 
found that the children with ASD were significantly less likely to have been breastfed. 
The absence of breastfeeding significantly increased the odds of a later ASD 
diagnosis and Schultz et al (2006) found that formulas supplemented with fatty acids 
(‘Gold’ formulas) were less likely to be associated with an ASD diagnosis. Brown, 
Austin & Busija (2014) and Al-Farsi (2012) found that first hour breastfeeding was 
negatively associated with autism. In addition, Brown et al (2014) found some 
evidence for fatty acid deficiency in the children with autism.  
 
Suboptimal breastfeeding is also correlated with birth interventions and neonatal risk 
factors such as low birthweight and prematurity, and many of the suboptimal 
breastfeeding risk factors are common with risk factors identified with ASD. A 
neonate with low birthweight, hypoxia, delivered by caesarean section or any other 
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risk factors commonly associated with elevated ASD risk, is more likely to receive 
suboptimal breastfeeding.  Donath and Amir (2008) found that neonates with 
gestational ages under 40 weeks were less likely to be breastfed. Breastfeeding 
initiation and maintenance is compromised after caesarean sections independent of the 
age of the mother (Fisher et al., 2013). Karlström, Lindgren, and Hildingsson (2013) 
found breastfeeding difficulties in women who had both emergency and elective 
caesareans.  
 
If ASD and suboptimal breastfeeding share some risk factors, it may be argued that 
birthing risk factors such as caesareans, artificial rupture of membranes (AROM), 
inductions and epidurals may cause an environment where the initiation and duration 
of breastfeeding is compromised.  
 
Breastfeeding 
 
 
Research has shown that breastmilk hydrates, provides beneficial gut bacteria and 
immunological protection to an infant, but the exact composition of breastmilk is still 
unknown (Hinde, 2013).  
 
The World Health Organization (WHO) recommends exclusive breastfeeding: that is, 
the infant only receives breast milk without any additional food or drink, not even 
water, on demand day and night for the first six months of life and that initiation of 
breastfeeding takes place within the first hour of life (WHO/UNICEF, 2003).  
WHO estimates that the achievement of universal coverage of optimal breastfeeding 
could prevent 13% of deaths in children under 5 (WHO, 2009).  
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A paediatric cost analysis in the U.S. estimated that if exclusive breastfeeding was 
attained for six months by 80-90% of families, the saving would be approximately 
$13 billion dollars per year by reducing costs associated with medical conditions such 
as otitis media, gastroenteritis, infectious diseases, necrotizing enterocolitis, asthma 
and atopic dermatitis (Bartick & Reinhold, 2010). At this time, it is estimated that 
exclusive breastfeeding rates are only 34.8% worldwide (WHO, 2009). 
 
Breastmilk 
 
In humans, and all mammals, lactation has three distinct stages: colostrum, 
transitional milk and mature milk, and at each stage the composition of the milk 
differs. Genetic analysis has found stage specific transcripts for immune defence in 
colostrum, milk protein synthesis in the transitional milk, and lipid production in 
mature milk (Lemay et al., 2013) indicating that each stage has a specific functional 
role. 
 
Colostrum 


Colostrum is a specialized milk produced in the first days after birth (Steimer & 
Klagsbrun, 1981) and due to the tight junctions in the mammary epithelium being 
open, many immunologically derived protective components from the mother’s 
circulation are transported into the colostrum (Rodriguez, Meier, Groer, & Zeller, 
2009). The tight junctions close over the first days post partum and transitional milk 
occurs (Rodriguez et al, 2009).  
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Colostrum at a concentration of 2%, contains more growth factor activity than mature 
milk at a concentration of 20% (Steimer & Klagsbrun, 1981) and in transitional milk 
protein levels fall as much as fivefold with lactose increasing by about 50% (Casey, 
1989).  
 
Colostral milk has been shown to support epithelial cell proliferation more than 
mature milk does and has been shown to be selective: supporting the growth of 
epithelial cells but not fibroblasts (Steimer and Klagsbrun, 1981).  In contrast, 
transitional milk (obtained one week post parturition) is completely inactive in terms 
of epithelial growth factors (Miller, 2008). The growth factors in colostrum seem to 
be involved in controlling the early growth and maturation of mammary epithelial 
cells of the neonatal intestine (Miller, 2008).  
 
Colostral milk contains immunoglobulins, predominantly IgA, which play an 
important role in gut mucosal immunity (Vassilev & Veleva, 1996) but it also 
contains IgG (Miller, 2008) and IgM (Koenig, de Albuquerque Diniz, Barbosa, & Vaz, 
2005). IgM is found in low concentrations in colostrum as the newborn is fully 
capable of producing IgM endogenously (Koenig et al, 2005).  In most species, 
immunoglobulins are absorbed through the neonatal intestinal epithelium for only a 
few hours post parturition and absorbed immunoglobulins enter the intestinal 
lymphatic system and then enter the neonatal blood circulation. Absorbed IgA is 
secreted onto mucosal surfaces of the neonate (Wagstrom, Yoon, & Zimmerman, 
2000) especially in the gut where it is generally thought to form an ‘immunopaint’ to 
prevent exposure of the mucosa and hence of the immature immune system, to 
environmental pathogens and other antigenic proteins (Casey, 1989).  Meanwhile, 
IgG remains in circulation (Wagstrom et al, 2000). The mean IgA concentration in 
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colostrum is significantly higher in mothers of very premature infants (less than 32 
weeks gestation) and decreases less rapidly than for term infants (Koenig et al, 2005). 
In this way, colostral composition seems to differ in response to the gestational age of 
the infant (Koenig et al, 2005; Rodriguez et al, 2008). Unfortunately, extremely low 
birth weight infants are often exposed to prolonged periods of nil by mouth and 
antibiotic exposure, leading to intestinal atrophy and an abnormal pattern of intestinal 
colonization (Rodriguez et al, 2008).  
 
 
Leukocytes are cells of the immune system that defend the body against both 
infectious disease and foreign materials and colostrum contains ten times the amount 
of leukocytes than mature breast milk. Most of these leukocytes are macrophages and 
neutrophils, which remove microbial pathogens. Lymphocytes, including T cells, 
natural killer cells, and antibody-producing B cells, make up 10% of the leukocytes in 
human breast milk (Jackson & Nazar, 2006).  
 
Calves deprived of maternal colostral leukocytes are found to lag behind in immune 
development by 1-2 weeks (Reber et al., 2008) and it is believed that the provision of 
maternal colostral leukocytes immediately after birth stimulates the development of 
the neonatal immune system and in this way is a part of the neonatal immune system 
(Reber et al, 2008).  
 
 
The regulation of metabolic homeostasis depends on nutritional status, energy 
expenditure and hormonal signals (Ben-Jonathan, Hugo, Brandebourg, & LaPensee, 
2006). The pituitary hormone, Prolactin (PRL) has more functions than all the other 
pituitary hormones combined (Ben-Jonathan et al, 2006). High concentrations of PRL 
are found in colostrum and fall rapidly in the days following birth: 157 ng/ml on the 
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third day compared with 24 ng/ml 13 days postpartum (Healy, Rattigan, Hartmann, 
Herington, & Burger, 1980).  In addition to the role it plays in initiating and 
maintaining lactation, PRL regulates enzymes and transporters that are associated 
with glucose and lipid metabolism in other target organs. With some genetic studies 
of ASD implicating the PRL system at the genetic level and the PRL pathway as a 
whole (Yrigollen et al., 2008), further study is warranted into the potential bioactivity 
of PRL in colostrum and breastmilk and whether it may be protective in regard to 
ASD. 
 
Breastmilk, colostrum, formula and EFAs 
 
The percentage content of Long Chain Polyunsaturated Fatty Acids (LCPUFAs) are 
twofold higher in colostrum when compared with mature milk and this is consistent in 
all lactating women in all parts of the world (Fidler & Koletzko, 2000). The fat 
globules in colostrum are larger than in transitional, mature and artificial milks 
(Michalski, Briard, Michel, Tasson, & Poulain, 2005). It is theorized that the larger fat 
globule size of colostrum in the first two days postpartum could be an adaptation to 
the immature digestive system of the neonate contributing to an efficient and rapid 
digestion of colostrum lipids (Michalski, 2005). New homogenization techniques in 
use in infant formula since 1984 use the emulsification of vegetable oils which means 
that the fat globules are much smaller in artificial milk than in human colostrum and 
mature milk (Michaelski, 2005) but it is not known how this may affect the infant. 
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Research implications 


Colostrum profiles very differently to transitional and mature milk and seems to have 
a different function. At this time, there is no artificial colostral substitute and infants 
that are fed artificially are fed formula based on the composition of mature milk.  
 
The commentary paper synthesises the findings outlined in these chapters and outlines 
the potential links between fatty acid deficiency and ASD, with a particular focus on 
the unique role of colostrum. The paper is a suggestion to researchers to differentiate 
between colostral milk and mature milk in human research the way it is expressed in 
animal research. The task of differentiating between milk stages is complex, however, 
with the discovery that the different milks are signified by a differentiation in 
potassium and sodium levels, rather than day of lactation (Lemay et al., 2013).   
 
The WHO breastfeeding guidelines recommend breastfeeding in the first hour due to 
the establishment of a breastfeeding relationship between the mother-infant dyad, but 
crucially, because it has been found that neonatal deaths in populations where the 
mortality rates are high, could be reduced by 22% if infants were fed within the first 
hour (Edmond et al., 2006).  In the Western world, the neonatal mortality rate is less 
than what is found in other parts of the globe, but the question remains: What does 
colostrum do in that first hour? A key proposition of the commentary paper is that 
colostral feeding in the first hour may assist an infant to lay down an immunological 
and metabolic pathway in a critical window of development. 
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Paper 1. Commentary: Breastfeeding and Autism Spectrum Disorder. Reprint of 
original article. 
 
1. Brown, C.M. & Austin, D.W. (2009). Breastfeeding and Autism Spectrum 
Disorder: Commentary. Electronic Journal of Applied Psychology: 
Innovations in Autism 5(1): 49-52. 
 
Reproduced with permission  
 
 
 
  
Autism Spectrum Disorder, Essential Fatty Acids and Infant Feeding 


?=

 
	

1.  Details of publication and executive author 
)"%*")%$ *")%$)"(
Commentary: Breastfeeding and Autism Spectrum Disorder ")'%$
%*'$"%&&"
(.%"%.
#%-*)+*)%' %%"8	$())*)8+(%$(
)!$1'$()%$$
'(($%$3!$
#"%'&%$
'()$'%,$ %%"%(.%"%. '()$2'%,$<!$2*2*
2.  Inclusion of publication in a thesis 
	()$)$)%$"*)(&*")%$$'
'.'('9:)((4
(


	(0&"(%#&"))%$@
	%0%()'))%)%$A2
3.  HDR thesis author’s declaration 
#%)((*)%'
'$)'%#%+29	)
(#0,')6(%+7:
%%"8	$())*)8+(%$(
)!$
(())"
(%+ %%"%(.%"%. Autism Spectrum Disorder, Essential 
Fatty Acids and Infant Feeding
	)''#*")&"*)%'(0+*""('&)%$%)((*)%'5(%$)'*)%$)%)&*")%$
9%'-#&"0%,#*.%*%$)'*))%)%$&)%$%)&'% )0)($%#)%%"%.%'
-&'#$)"&'%)%%"0)%"")%$0$".((0')$)#$*('&)0'+($)')"".%'#&%')$)
$)"")*"%$)$)0)2:

())((*)%'0	'(')")')*'%')(&&'0,'%)$($)&&'0'+()
')"".$,('(&%$("%')$"')2

 
#$
!&
$)*'
$) 

>E8>8?=>B
4.  Description of all author contributions 
#$")%$%*)%' %$)'*)%$9(:9%'-#&"0%$&)%$%)&'% )0($%
#)%%"%.%'-&'#$)"&'%)%%"0)%"")%$0$".((0
')$)#$*('&)0'+($)')"".%'#&%')$)$)"")*"
%$)$)0)2:

'()$'%,$0!$
$+'().


%$&)%$0")')*''+,0')$#$*('&)

+*()$0!$$+'().


')"'+(%$$)$
Autism Spectrum Disorder, Essential Fatty Acids and Infant Feeding 


?>

 
!$%
&  
 #
#$
& $
& 	-#)*$
 & !	.
!&
!	+,$
 & (

 #$!$
# #) # *&

#%*)%' $)*'; )

'()$'%,$0!$$+'().
 
>E8>8>B

+*()$0!$$+'().
 
>E8>8>B
!	
'!&
#$")%$%%$)'*)%' %$)'*)%$ $)*';$)


 
	$*)%'%'%$)'*)%'(*$+""%'%)',(*$")%($)())#$)%
*)%'(&0)%#$)#.($%$)'"0$%)$)'(%$%')'
*$+"").0&'%+)'($%+$)%(*())))&'(%$,%*"% ))%$
$#(*)%'
"
%'$")%')(&'% )'()%'$)%""%,$"%)%$(29"%)%$(#*()
,)$$&&'%&')$())*)%$"())$2	)-*)+*)%'(!$()##'$
)'()%'%*)(!$$+'().0&'#((%$%')(#*()+$.)%
#$),)$,)-*)+*)%'((2:
)%'#) )%'%)%$ )"% #%*()%$
%)')$)-*)+
*)%'
%)&&""   
 
  
Autism Spectrum Disorder, Essential Fatty Acids and Infant Feeding 


??

 
 
 
 
Autism Spectrum Disorder, Essential Fatty Acids and Infant Feeding 


?@

 
 
 
 
Autism Spectrum Disorder, Essential Fatty Acids and Infant Feeding 


?A
  
Autism Spectrum Disorder, Essential Fatty Acids and Infant Feeding 


?B

 
 
  
Autism Spectrum Disorder, Essential Fatty Acids and Infant Feeding 


?C

Chapter 4: ASD and phospholipids 

A disruption of membrane phospholipid metabolism was originally proposed by 
Horrobin, Glen, and Vaddadi (1994) as the possible etiological basis of schizophrenia 
and is known as the membrane hypothesis of schizophrenia. The concept proposes 
that brain phospholipid metabolism is altered because of an increased rate of loss of 
DGLA(20:3, n-6), EPA(20:5, n-3), AA(20:4, n-6) and DHA(22:6, n-3) from the Sn2 
position of phospholipids. This loss leads to changes in the functioning of the 
membrane-associated proteins and of the cell signalling systems. One explanation for 
this is thought to be overactivity of one or more of the PLA2 group of enzymes that 
remove these EFAs from the Sn2 position. This review paper investigates the 
possibility that underlying phospholipid dysregulation may also be operant in ASD. 
The paper also hypothesises that breastfeeding initiation and duration could be 
associated with fatty acid deficiency.  
  
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Paper 2: Autistic disorder and phospholipids: A review. Reprint of original 
article 
 
Brown, C.M. & Austin, D.W. (2010). Autistic disorder and phospholipids: A review, 
Prostaglandins Leukotrienes Essential Fatty Acids. 84 (1): 25-30 . 
 
Reproduced with permission from Elsevier.  
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Chapter 5: Observable fatty acid markers  
 
In 1995, Stevens et al. (1995) published a study of boys with a diagnosis of ADHD. 
This paper outlined seven clinical fatty acid deficiency markers: excessive thirst, 
frequent urination, dry hair and skin, brittle or soft nails, dandruff and rough, bumpy 
skin (keratosis pillaris) and the association of these signs with plasma polar lipid fatty 
acid levels. The authors found that a high fatty acid deficiency (FAD) score, as 
measured by the seven observable signs, was significantly associated with low levels 
of LCPUFAs, in particular, DHA. Additionally, those boys without an ADHD 
diagnosis were significantly less likely to have been breastfed (81% versus 45%) and 
the breastfeeding duration in the neurotypical cohort was significantly longer than in 
the boys with ADHD (6.5 months versus 2.5 months).  
 
In 2001, Vancassel (2001) found that children with an ASD diagnosis had 
significantly lower levels of plasma fatty acids, in particular, 20% less DHA than 
controls. Amminger (2006) found that n-3 fatty acid supplementation attenuated ASD 
symptomatology and Antalis (2006) again found a correlation between observable 
fatty acid deficiency and low DHA plasma phospholipid. Whilst this study showed 
plasma levels deficiency in ASD, blood levels of EFA were not significantly different 
to controls. This may have indicated a fatty acid conversion issue, but it was not 
explored in the paper.  
 
In 2004, Bell found significant differences in the fatty acid deficiency (FAD) markers 
in individuals with autism, Asperger’s and the control group. However, in 2007, Sinn 
published a paper that found that although the FAD score predicted lower fatty acid 
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levels and a lower rate of breastfeeding in individuals with ADHD, it was not a 
reliable way of identifying those who could benefit from fatty acid supplementation. 
This study seems to be the most recent paper published that reported using the FAD 
measure.  
 
An alternative measure of fatty acid status is organic acid testing, which is a technique 
that uses liquid chromatography tandem mass spectroscopy to test for organic acids in 
urine. Tandem mass spectroscopy is used to assess for inborn errors of metabolism 
such as phenylketonuria (PKU) (Ozben, 2013), however organic acid testing seeks to 
measure subclinical levels of organic acids.  After researching, investigating and 
analysing data on Organic Acid Testing as a potential biomarker for fatty acid 
metabolic dysregulation or deficiency, several issues were identified. Firstly, there 
were issues with regards to accepted reference ranges and also their specificity to 
detect dysregulation associated with issues of fatty acid metabolism. Furthermore, the 
test was found to be more onerous for parents and children as a first morning urinary 
sample must be supplied. Ultimately, the decision was made to use the observable 
signs of fatty acid deficiency: the FAD score (Bell, 2004).   
 
The following paper concentrated on breastfeeding and FAD scores. The intent was to 
ascertain whether first hour colostral feeding would be significantly associated with 
an ASD diagnosis and whether the seven observable fatty acid deficiency signs would 
correlate with a diagnosis of ASD as they had in the study by Bell (2004).  
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Paper 3: Observable fatty acids and Autism spectrum disorder, reprint of 
original article 
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Chapter 6 – Breastfeeding initiation and duration  

In the previous study (Brown, Austin, & Busija, 2014), a very strong relationship 
between fatty acid deficiency (FAD) scores, first hour breastfeeding and ASD was 
found. Due to these findings, a study was devised to address some of the limitations in 
the pilot paper.  
 
Firstly, a larger sample size was obtained and a more heterogeneous sample was 
recruited by advertising for participants from the general population and also at a 
home birth conference. Women who plan homebirths are often older than women in 
hospital settings and are less likely to be first time mothers, but crucially, are 
significantly more likely to have a spontaneous onset of labour (no induction), no 
epidural or spinal analgesia, no forceps, vacuum extraction or caesarean section 
(Homer et al., 2014). It was thought that this population would provide a measure of 
what Homer et al. defined as ‘normal labour and birth’.  
 
The FAD measure was re-designed to improve sensitivity by gathering responses via 
a Likert scale, rather than asking for the presence or absence of a given symptom. A 
breastfeeding duration measure was included and pre-natal risk factors commonly 
associated with ASD were also included in the survey.  
 
Subsequent to the publication of Autistic Disorder and Phospholipids: A review 
(Brown & Austin, 2011) and the commentary paper, Fatty Acids, Breastfeeding and 
Autism Spectrum Disorder (Brown & Austin, 2009) calling for research into the 
relationship between first hour colostral feeding and ASD, researchers published a 
study that found that first hour breastfeeding and breastfeeding duration were 
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significantly associated with ASD diagnosis (Al-Farsi et al., 2012). This paper, 
entitled ‘Effect of suboptimal breast-feeding on occurrence of autism: a case control 
study’ (Al-Farsi et al., 2012), included a measure of breastfeeding delay to account for 
colostral intake. Although the researchers did not find a significant association 
between ASD diagnosis and breastfeeding delay, this variable was included in this 
larger study to assess whether a larger and more heterogeneous sample would reveal 
any effect.  
 
This paper was designed to extend the findings of the pilot paper, ‘Observable 
essential fatty acid deficiency markers and Autism Spectrum Disorder’ (C. M. Brown 
et al., 2014) and to continue in the research direction of Al-Farsi et al. (2012). With a 
population in the analysis more likely to have a normal labour and birth, the study was 
designed to assess whether birth interventions could be risk factors for ASD due to 
their role in the disruption of the initiation and duration of breastfeeding. Further, 
whether a lack of breastfeeding in the first hour and a shorter duration of 
breastfeeding would impact the fatty acid status of an infant and potentially increase 
the risk of an ASD diagnosis. 
 
A cluster adjusted path analysis was used to test the model to ascertain whether 
evidence suggested that the FAD scale (as a measure of fatty acid deficiency) could 
be a mediating factor between breastfeeding duration and a diagnosis of ASD, after 
accounting for within-family clustering. It was hypothesised that the impact of 
obstetric risk factors such as caesareans would be less influential in the model when 
breastfeeding factors were included.  
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Paper 4:  Staying the Course: Breastfeeding duration as a protective factor in 
ASD and fatty acid deficiency.  
 
Brown, C.M., Busija, L., Shandley, K., Austin, D.W., Staying the Course: 
Breastfeeding duration as a protective factor in ASD and fatty acid deficiency.  
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Abstract 
 
There is evidence that Autism Spectrum Disorder (ASD) is associated with essential 
fatty acid (EFA) deficiencies. This study investigated the relationship between 
breastfeeding duration, exclusivity and first hour colostral feeding, fatty acid 
deficiency and ASD diagnosis. A survey was conducted with biological mothers of 
3,570 children aged between 3-13. When considered within their family group, a dose 
effect of breastfeeding was found with children receiving a longer duration of 
breastfeeding being significantly less likely to have an ASD diagnosis. Fatty acid 
deficiency was found to have a mediating effect between breastfeeding duration and 
ASD diagnosis. First hour breastfeeding, and exclusive breastfeeding were both 
significantly correlated with reduced fatty acid deficiency symptoms whilst a delay in 
breastfeeding initiation was significantly correlated with increased fatty acid 
deficiency symptoms. When fatty acid status, breastfeeding and family characteristics 
were accounted for in the model, low birth weight, pre-term birth, artificial rupture of 
membranes, birth by caesarean section and epidurals were all found to be non-
significant in predicting ASD diagnosis. The results of this study indicate that 
breastfeeding factors may have a protective role in ASD and that the initiation and 
continuation of breastfeeding may play a crucial role at a critical juncture in infant 
development.  
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Introduction 
 
ASD is a complex disorder that affects the social, behavioural, emotional and 
biological functioning of individuals [Shandley & Austin, 2010]. ASD is normally 
identified in children before their third birthday and by the age of eight, the Centers 
for Disease Control and Prevention now estimate that as many as 1 in 68 have an 
ASD diagnosis [Centers for Disease Control, 2014]. This statistic, based on data from 
2010, is a 123% increase since 2002 [Centers for Disease Control, 2014]. Greater 
efficiencies in identification and diagnosis seem less and less plausible as an 
explanation for the entirety of the increase [Yeargin-Allsopp et al., 2003; Rice et al., 
2012; Schieve et al., 2014].  
 
Currently, it is generally accepted that ASD is likely determined by both genetic and 
environmental factors [Grafodatskaya et al., 2010] although there is very little 
agreement as to what these factors might be and how they might interact. One study 
[Hallmayer et al., 2011] estimated that environmental influences may explain up to 
55% of the variation in ASD diagnoses over and above genetics. An important 
consideration is that the effects of some genes are conditional on environmental 
exposures [Caspi et al., 2007].  
 
One environmental risk factor identified in ASD is suboptimal breastfeeding. 
Breastfeeding duration has repeatedly shown a relationship with ASD; that is, the 
longer the duration of breastfeeding, the less likelihood of an ASD diagnosis [Tanoue 
Autism Spectrum Disorder, Essential Fatty Acids and Infant Feeding 


BA

& Oda, 1989; Schultz et al., 2006; Al-Farsi et al., 2012]. Tanoue and Oda [1989] 
found that if infants had been breastfed for less than a week, then they were more 
likely to have an ASD diagnosis. Schultz [2006] and Al-Farsi [2012] both found ASD 
to be significantly associated with the duration of breastfeeding in the infant and 
previous research has also found that the likelihood of an ASD diagnosis increases if 
an infant is not breastfed within the first hour of birth [Al-Farsi et al., 2012; Brown et 
al., 2014].  
One of the reasons suboptimal breastfeeding may be a risk factor for ASD is a 
reduction in access to Long Chain Polyunsaturated Fatty Acids (LCPUFAs) at a 
crucial time in the infant’s development. A class of lipids, LCPUFAs influence health 
and development throughout the lifespan [Janssen & Kiliaan, 2014]. The ability to 
metabolise LCPUFAs is inherited, but the precursor Essential Fatty Acids (EFAs) 
LA(n-6) and ALA(n-3), must be provided via dietary sources. For much of their 
biological activity, the EFAs LA and ALA require conversion by Delta6 desaturase 
enzymes into LCPUFAs: AA, EPA, DPA and DHA [Gibson et al., 2011].  
The LCPUFA that has gained importance in the literature is the n-3 fatty acid, DHA. 
DHA is involved in brain development, gene expression and function [Crawford et al., 
2014] and there is now wide agreement that DHA has a unique and irreplaceable role 
in brain lipid and photoreceptor structure [Guesnet & Alessandri, 2011]. DHA also 
influences growth, metabolism and immune outcomes in childhood [Gibson & 
Makrides, 2000].  
Human milk is a crucial source of DHA and breastfed infants show higher levels of 
DHA when compared with infants receiving formula unsupplemented with DHA 
[Makrides et al., 1994]. Cortical levels of DHA have been found to be dependent on 
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breastfeeding duration [Makrides et al., 1994; Farquharson et al., 1995] and infant 
formula containing only the precursor fatty acids LA and ALA may not be effective in 
meeting the full EFA requirements of the infant [Simmer et al., 2008]. Alterations in 
neurotransmission, learning and development that are caused by fatty acid 
deficiencies in the pre- and post-natal period may be irreversible and not able to be 
remediated with supplementation [Guesnet & Alessandri, 2011].  
As individuals diagnosed with ASD have been shown to have significantly lower 
LCPUFA levels than controls [Vancassel et al., 2001; Bell et al., 2004; Bu et al., 
2006; Bell et al., 2010; El-Ansary et al., 2011] there is the potential that the length of 
breastfeeding an infant receives may impact their fatty acid status and thereby 
increase their risk of ASD. A number of studies have found that seven observable 
symptoms of fatty acid deficiency correlate with low LCPUFA levels in plasma 
[Stevens, Zentall, & Deck, 1995; Bell et al., 2004; Antalis et al., 2006]. Dry hair, dry 
skin or skin that is rough and bumpy, brittle nails, dandruff, frequent thirst and 
urination are all clinical signs of EFA deficiency [Bell et al., 2004]. Stevens, Zentall, 
Deck, et al. [1995] found that these seven signs also correlated with breastfeeding 
duration in a study of boys with a diagnosis of ADHD.  
Environmental risk factors associated with suboptimal breastfeeding include 
prematurity [Donath & Amir, 2008], low birth weight and caesarean birth [Sutherland 
et al., 2012; Brown & Jordan, 2013; Fisher et al., 2013]. Giving birth by caesarean 
section often separates the mother and child for an extended time and a critical 
window is missed for the establishment of breastfeeding [Cakmak & Kuguoglu, 2007; 
Brown & Jordan, 2013]. Epidural anaesthesia has also been associated with 
breastfeeding cessation within one month [Dozier et al., 2013].  
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Despite the somewhat varied and inconsistent nature of the findings from ASD risk 
factor research, suboptimal breastfeeding and ASD share risk factors such as 
advancing parental age [Gentile et al., 2013], caesarean and preterm birth [Langridge 
et al., 2013] and low birthweight [Gardener et al., 2011]. It is possible that the 
contribution of pre- and post-natal risk factors commonly associated with ASD may 
be due to the creation of a suboptimal breastfeeding environment that contributes to 
an increased risk of an ASD diagnosis.  
This study sought to investigate the relationship between ASD diagnosis, 
breastfeeding duration and fatty acid deficiency. Birth interventions and perinatal 
factors that were found in the literature to be associated with both ASD diagnosis 
[Froehlich-Santino et al., 2014; Schieve et al., 2014] and suboptimal breastfeeding 
[Limperopoulos, 2009; Mamidala et al., 2013] were included in the analysis as 
covariates.  
The two main foci of this study were to determine the role of breastfeeding duration 
in ASD, after controlling for relevant confounders and to determine whether fatty acid 
deficiency may have a mediational role in the relationship between breastfeeding 
duration and ASD diagnosis.  
Method 
Participants  
Following receipt of ethics approval from Swinburne University Human Research 
Ethics Committee, an online health survey was advertised in an Australian parenting 
magazine, on Autism support websites at special education schools and was also 
publicised at a homebirth conference in Echuca (Victoria, Australia) in May 2010. 
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The survey asked for the participation of biological mothers of children from 3 to 13 
years of age. The survey was referred to as a ‘Pregnancy, birth, infant feeding and 
child health outcome’ survey or a ‘Health Survey’ and at no time made reference to 
autism.  
Data were collected between 2011 and 2012. In total, 2,473 biological mothers of 
4,306 children consented to take part in the survey. The survey responders provided 
data on 3,570 children, a completion rate of just over 80%. The remaining 736 survey 
respondents gave their demographic details, but did not complete details for their 
children and these data were therefore not included in the analyses.  
Measures  
Health survey  
The Pregnancy, birth, infant feeding and health outcome survey was designed for the 
present study. It comprised four main sections:  
1. The demographic and health information of the biological parents;  
2. The pregnancy histories of the biological mothers;   
3. The birth and early feeding history of each participating child; and   
4. The health outcomes of each participating child.   
Mothers were asked if their child was born at home, in hospital or at a birthing centre 
and whether or not they had birth interventions such as caesareans, artificial rupture of 
membranes, epidurals or an induction of labour. Both hospital births and birthing 
centre births were coded as having been born in a hospital.  
The feeding history of the children gathered information specific to the first hour after 
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birth and also gauged breastfeeding duration and exclusivity. The question in regard 
to the exclusivity of breastfeeding was phrased, ‘Was your child exclusively 
breastfed? (That is, no formula, no water, no other liquids or substances until solid 
foods introduced?)’. Mothers were also asked how many days after their infant’s birth 
they began breastfeeding and then how many days or weeks elapsed before they 
discontinued. Breastfeeding duration was coded into months for the analysis.  
The presence or absence of an ASD diagnosis was ascertained by the questions, ‘Has 
your child been diagnosed with Autism, Asperger’s Syndrome or an Autism Spectrum 
Disorder (such as Pervasive Developmental Disorder)? And ‘What diagnosis did your 
child receive?’ The answers given were collapsed into ASD consistent with DSM-5 
classification.  
Fatty Acid Deficiency (FAD) status  
Fatty Acid Deficiency (FAD) was measured using the seven clinically observable 
signs: excessive thirst, frequent urination, dry skin, dry hair, soft or brittle nails, 
dandruff and rough, dry, bumpy skin. The FAD scale has been used by researchers to 
determine fatty acid deficiency in a non-invasive way and shown to correlate with 
plasma fatty acid levels [Stevens, Zentall, & Deck, 1995; Bell et al., 2004; Sinn, 
2007].  
The FAD questions were phrased, ‘In general, please rate your child’s tendency to 
suffer from the following’ and listed the seven signs with a Likert rating scale:  
0 = Not at all 1 = Sometimes 2 = Frequently 3 = Always  
The minimum FAD score was 0 with a maximum score of 21.  
 
Autism Spectrum Disorder, Essential Fatty Acids and Infant Feeding 


BF

Statistical analysis:  
The relationship between FAD status, breastfeeding duration (in months) and ASD 
was tested using path analysis [Muthén & Muthén, 2012] with observations clustered 
within families. Path analysis tested direct effects of breastfeeding duration and FAD 
status on ASD, controlling for prognostic factors such as gestational age, birthweight 
and birth interventions. The model also specified an indirect effect from breastfeeding 
duration to ASD through FAD status. FAD status was modelled as a latent variable, 
with the seven symptoms of FAD used as indicators. The path analysis used mean and 
variance adjusted weighted mean squares (WLSMV) estimator for all parameters. 
Given that this study collected data on all children from participating families, child 
per family, path analysis utilised cluster-adjusted standard errors to account for the 
within-family clustering of the children. Path analysis was carried out in Mplus 
Version 7.11 (Muthen & Muthen, 1998-2013, Mplus software. Los Angeles, CA). 
Missing data ranged from 0.9% on the fatty acid deficiency variable excessive thirst 
to 9.6% on induction of labour. Missing data were assumed to be missing at random 
and were handled with pairwise deletion (a default approach to missing data handling 
in Mplus software when WLSMV estimator is used).  
 
Results 
Demographic details, pre- and post-natal interventions and feeding details of study 
participants can be found in Table 1. The significance levels in Table 1 were 
determined by One-way analysis of variance (ANOVA) and Chi-Square tests.  
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a  AROM: Artificial Rupture of Membranes 
b NICU: Neonatal Intensive Care Unit 
 
 
  
 
Table 1: Demographic, intervention and feeding details of children with and without a 
diagnosis of Autism Spectrum Disorder 
 Autism Spectrum  
Disorder (ASD) 
 
(n=335) 
No Autism 
Spectrum Disorder 
(non-ASD) 
(n = 3235) 
Total 
 
 
(n=3570) 
p  
     
Maternal age M 31.10 (SD 5.7) M 30.15 (SD 5.1) M 30.24 (SD 5.16) <.01 
Paternal age M 33.53 (SD 6.09) M 32.61 (SD 6.00) M 32.70 (SD 6.01) <.01 
Total FAD score M 3.53 (SD 3.30) M 1.71 (SD 2.02) M 1.88 (SD 2.22) <.01 
 
Gender 
- Female 
-  Male 
 
 
79 (23.6%) 
256 (76.4%) 
 
 
1609 (49.7%) 
1618 (50.0%) 
 
 
1749 (40.6%) 
1940 (45.1%) 
 
 
<.01 
 
Premature 
(<37 weeks) 
 
37 (11%) 
 
176 (5.4%) 
 
220 (5.1%) 
 
<.01 
 
Low birthweight 
(<2,500 gms) 
 
 
35 (10.4%) 
 
164 (5.1%) 
 
205 (4.8%) 
 
<.01 
Place of birth 
- Home 
- Hospital 
 
 
14 (4.2%) 
320 95.5%) 
 
797 (24.6%) 
2395 (74.0%) 
 
841 (19.5%) 
2851 (66.2%) 
 
<.01 
<.01 
Birth interventions 
- Induction 
- AROM a 
- Epidural 
- Caesarian 
 
166 (49.6) 
86 (25.7%) 
106 (31.6%) 
68 (20.3%) 
 
1135 (60.5%) 
751 (23.2%) 
735 (23.2%) 
512 (15.8%) 
 
1371 (31.8%) 
879 (20.4%) 
873 (20.3%) 
602 (14%) 
 
 
<.01 
n.s. 
<.01 
<.05 
Post natal 
- Jaundice 
- First Hour resus 
- First Hour NICUb 
- First Hour h/crib 
 
Breastfeeding 
- Duration (months) 
- First hour 
- Exclusive 
- Delay (>3 days) 
 
 
154 (46%) 
11 (3.3%) 
39 (11.6%) 
44 (13.1%) 
 
 
11.23 (SD 10.36) 
205 (61.2%) 
146 (43.6%) 
11 (3.3%) 
 
991 (30.6%) 
106 (3.3%) 
162 (5.0%) 
181 (5.6%) 
 
 
18.00 (SD 12.38) 
2548 (78.8%) 
2092 (64.7%) 
37 (1.1%) 
 
1173 (27.2%) 
118 (2.7%) 
205 (4.8%) 
232 (5.4%) 
 
 
M 17.00 (SD12.37) 
2820 (65.5%) 
2289 (53.2%) 
48 (1.1%) 
 
<.01 
n.s. 
<.01 
<.01 
 
 
<.01 
<.01 
<.01 
<.01 
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Fit between the path model and observed data was assessed with a range of fit indices. 
Non-significant chi-square goodness-of fit (p>0.05), comparative fit index (CFI) and 
Tucker-Lewis index (TLI) values >0.95, and root mean square error of approximation 
(RMSEA) values <0.06 were interpreted as indicating good fit of the path model (Yu, 
2002).  Model goodness-of-fit statistics are reported in Table 2. 
Table 2: Model fit statistics for path analysis 

Model Fit Information 
Chi-Square Test of Model Fit 
Value 1148.250 
Degrees of freedom 134 
p-value 0.00 
Root Mean Square Error of Approximation (RMSEA) 0.044 
90% Confidence Interval 0.042-0.047 
Probability RMSEA <= .05 1.00 
CFI/TLI 
CFI 0.861 
TLI 0.636 
 
The path model explained 39.5% of the variation in ASD diagnosis and 4.2% of the 
variation in FAD status.  
After accounting for demographic characteristics and birth-related factors, 
breastfeeding duration was significantly associated with ASD diagnosis both directly 
and indirectly through FAD status.  
Results showed that ASD diagnosis was more likely to be present with shorter 
duration of breastfeeding and more FAD symptomatology. Longer breastfeeding 
duration was significantly associated with lower FAD symptomatology and 
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consequently, lower risk of ASD diagnosis.  Male gender was significantly associated 
with an increased risk of ASD diagnosis, as was older maternal age. 
Hospital birth was significantly associated with an ASD diagnosis. However, birth 
interventions such as inductions, artificial rupture of membranes (AROM), caesarean 
section, and epidurals were not significantly associated with ASD. 
First hour resuscitation, use of a humidicrib in the first hour after birth, admission into 
the Neonatal Intensive Care Unit (NICU) after birth, low birth weight, jaundice, and 
preterm birth were all non-significant in the model. Paternal age was also non-
significant in the model. Maternal education level just reached significance in the 
model, with a higher level of maternal education associated with a reduction in the 
likelihood of an ASD diagnosis. 
The probability of an ASD diagnosis did not increase significantly if a child did not 
receive breastmilk in the first hour after birth was not exclusively breastfed or if 
breastfeeding was delayed. However, first hour breastfeeding was significantly 
negatively correlated with FAD symptomatology as was exclusive breastfeeding, 
whilst a delay in breastfeeding was significantly positively correlated with FAD 
symptomatology. 
Whilst birth interventions were not significantly associated with an ASD diagnosis 
directly, significant correlations were found between birth interventions and 
breastfeeding duration. Inductions, AROM, epidurals, caesareans first hour 
humidicrib and first hour admission to the NICU were all negatively correlated with 
breastfeeding duration. Being born in a hospital setting was also negatively correlated 
with breastfeeding duration.  
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Significant positive correlations were found between breastfeeding in the first hour 
after birth and exclusive breastfeeding with an increase in breastfeeding duration. 
Standardised and unstandardised regression coefficients, confidence intervals and p 
values for the path analysis can be found in Table 3 and a diagram of the path analysis 
can be found in Figure 1. 
Table 3: Standardised and unstandardised regression coefficients, confidence 
intervals and p values for path analysis 
  
Unstandardised 
regression 
coefficient 
Unstandardised 95% 
Confidence Intervals p 
Standardised 
regression 
coefficient 
Predictors of ASD diagnosis: direct 
effects  
Fatty Acid Deficiency (FAD)  1.748 1.447 2.050 0.000 0.347 
Breastfeeding duration -0.011 -0.016 -0.005 0.001 -0.130 
Breastfeeding delay (>3 days) -0.227 -0.592 0.138 0.306 -0.026 
Breastfeeding first hour -0.103 -0.281 0.074 0.338 -0.044 
Exclusive breastfeeding -0.031 -0.155 0.093 0.681 -0.015 
Born in hospital 0.602 0.377 0.827 0.000 0.253 
Induced 0.115 0.000 0.230 0.101 0.056 
Artificial Rupture of membranes -0.142 -0.263 -0.020 0.055 -0.060 
Epidural -0.044 -0.173 0.086 0.579 -0.018 
Caesarean -0.180 -0.371 0.012 0.122 -0.066 
Low birth weight (< 2500 gms) 0.074 -0.201 0.348 0.659 0.017 
Preterm (< 37 weeks) -0.089 -0.367 0.188 0.596 -0.021 
Gender -0.539 -0.633 -0.446 0.000 -0.269 
First hour humidicrib 0.115 -0.977 1.206 0.863 0.028 
First hour NICUa 0.109 -0.135 0.353 0.462 0.025 
First hour resuscitation -0.241 -0.513 0.031 0.145 -0.042 
Jaundice 0.097 -0.006 0.200 0.120 0.045 
Father's age 0.005 -0.007 0.016 0.503 0.028 
Mother's age 0.024 0.011 0.036 0.002 0.123 
Mother's education level -0.169 -0.301 -0.037 0.035 -0.061 
Regression of FAD on b/feeding 
duration -0.006 -0.007 -0.004 0.000 -0.205 
Indirect effect of b/feeding duration on 
ASD diagnosis through FAD -0.010 -0.013 -0.007 0.000   
a NICU: Neonatal Intensive Care Unit 
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Figure 1: Cluster adjusted path analysis. Note: AROM: Artificial Rupture of 
Membranes, NICU: Neonatal Intensive Care Unit, B/F: Breastfeeding, LBW: Low 
birthweight, MAT/PAT: Maternal/Paternal, Edu: Education , Induct: Induction 
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Standardised correlations and significance values for breastfeeding duration and other 
feeding conditions, interventions and FAD symptomatology can be found in Table 4.  
Table 4: Standardised correlations and significance for breastfeeding, fatty acid 
symptomatology and interventions.  
 Estimate p 
Breastfeeding duration with: 
Induction -0.218 0.000 ** 
AROM -0.136 0.000 ** 
Epidural -0.213 0.000 ** 
Caesarean -0.113 0.000 ** 
Low Birth Weight -0.108 0.000 ** 
Preterm -0.122 0.000 ** 
Hospital birth -0.395 0.000 ** 
Gender 0.018 0.268 
First hour humidicrib -0.087 0.000 ** 
First hour NICU -0.057 0.002 * 
First hour resus -0.012 0.474 
Jaundice -0.081 0.000 ** 
Paternal age 0.096 0.000 ** 
Maternal age 0.085 0.000 ** 
Maternal education level 0.031 0.143 
First hour breastmilk 0.200 0.000 ** 
Exclusive Breastfeeding 0.458 0.000 ** 
Delay in breastmilk >3 days -0.098 0.059 
FAD symptomatology with: 
Induction 0.053 0.048 * 
AROM 0.053 0.022 * 
Epidural 0.050 0.029 * 
Caesarean 0.008 0.734 
Low Birth Weight 0.026 0.297 
Preterm 0.051 0.028 * 
Hospital birth 0.083 0.001 ** 
Gender 0.005 0.810 
First hour humidicrib 0.083 0.000 ** 
First hour NICU 0.076 0.000 ** 
First hour resus 0.043 0.026 * 
Jaundice 0.108 0.000 ** 
Paternal age -0.002 0.942 
Maternal age -0.044 0.095 
Maternal education level -0.043 0.107 ** 
First hour breastmilk -0.098 0.000 ** 
Exclusive Breastfeeding -0.079 0.000 ** 
Delay in breastmilk >3 days 0.124 0.000 ** 
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Discussion  
This research found that a longer duration of breastfeeding was significantly 
associated with lower FAD symptomatology and less likelihood of a diagnosis of 
ASD. Fatty acid status was found to have a mediating effect between breastfeeding 
duration and ASD.  
Breastfeeding duration  
These findings support the findings of previous studies that breastfeeding duration 
may act as a protective factor for both ASD [Tanoue & Oda, 1989; Schultz et al., 
2006; Al-Farsi et al., 2012] and fatty acid status [Makrides et al., 1994; Stevens, 
Zentall, & Deck, 1995; Koletzko et al., 2001]. The lack of a significant association 
between first hour breastfeeding and ASD contradicts previous research [Al-Farsi et 
al., 2012; Brown et al., 2014], but the finding that breastfeeding delay is not 
significantly associated with ASD diagnosis replicates previous research [Al-Farsi et 
al., 2012]. However, given the strong correlation between both first hour 
breastfeeding, exclusive breastfeeding and fatty acid deficiency symptomatology, 
more research is needed into the timing of breastfeeding and its potential health 
benefits. 
Microarray studies of the RNA of human milk have found that the stages of milk 
production appear to have different foci [Lemay et al., 2013]. The first stage, colostral 
milk, produces gene activity that encodes immunological factors. The second stage, 
transitional milk, contains gene activity that turn off the hormone that degrades 
protein and in the third stage, mature milk, gene activity focuses on lipid synthesis 
[Lemay et al., 2013]. Given this evidence for the ‘staged’ functionality of breastmilk, 
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it may be that in the beginning, first hour colostrum provides specific and crucial 
immunological instructions to the neonate. As high levels of LCPUFAs circulate in 
the full term neonate after placental transfer in the last trimester, perhaps an infant 
uses its lipid stores in the first few days whilst adapting and calibrating its immune 
system to life outside the womb. When the mature milk arrives, the gene activity in 
the milk that encourages lipid synthesis may be to assist in the neonate’s neurogenesis. 
This could be an explanation as to why it is longer exposure to breastmilk that seems 
to have the protective effect on ASD in susceptible individuals. As our results indicate, 
longer duration of breastfeeding significantly decreased the probability of ASD 
diagnosis.  
Risk factors  
In this study, when fatty acid status, breastfeeding and family characteristics were 
accounted for in the path model, low birth weight, a gestational age of less than 37 
weeks, and birth interventions such as AROM and epidurals were all non-significant. 
These findings differ from those reported in the literature, with low birth weight and 
pre-term birth [Gardener et al., 2011] found to be significant predictors of ASD. This 
study also contradicted the findings of Gregory et al. [2013] with induction of labour 
not significantly associated with ASD.  
However, risk factors traditionally associated with ASD were significantly correlated 
with breastfeeding duration. That is, pre-term birth, jaundice, induction, AROM, 
epidurals, caesareans and spending the first hour of life in the NICU or a humidicrib 
were significantly correlated with a reduction in breastfeeding duration. This lends 
support to the notion that it may not be useful to view interventions as risk factors per 
se, but as disruptors of breastfeeding initiation and maintenance.  
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In contrast, first hour and exclusive breastfeeding were both significantly correlated 
with longer periods of breastfeeding. In light of the strong association found in this 
study between breastfeeding duration and ASD, birth interventions that disrupt the 
initiation and maintenance of breastfeeding may contribute to an ASD diagnosis 
immunologically and nutritionally because a critical window for establishing optimal 
breastfeeding is missed.  
The significant association between hospital birth and reduction in breastfeeding 
duration may be due to the reduced number of birth interventions in homebirths and 
therefore an environment more conducive to first hour breastfeeding and the 
establishment of a breastfeeding routine. Homer et al. [2014] found that women who 
birthed their infants at home were significantly more likely to have a spontaneous 
onset of labour, have no epidural, spinal analgesia, caesarean or episiotomy. The 
obvious point here is that women birthing at home may also have less pregnancy 
complications and risk factors requiring hospital intervention.  
Gender and maternal age  
This study found that female infants and children born to younger mothers had lower 
probability of ASD diagnosis, however older mothers were more likely to breastfeed 
for longer. Despite the longer breastfeeding duration, it is possible that an older 
woman’s fatty acid stores are more depleted than a younger female meaning less 
available fatty acids in breastmilk for the breastfeeding infant.  
The finding in this study that boys were significantly more likely to have an ASD 
diagnosis is consistent with the extensive body of literature into ASD prevalence.  
When considering gender from a fatty acid perspective, it is worth considering that 
females may have an advantage when synthesising DHA from precursor fatty acids 
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[Makrides, 2013].  A recent review by Lohner et al (2013) of 51 studies found 
significantly higher levels of AA and DHA in the plasma total lipids and plasma 
phospholipids of females [Lohner et al., 2013]. Both human and animal studies show 
compelling evidence of sex differences in both DHA status and capacity to convert 
LA to DHA [Sibbons et al., 2014]. Caspi et al. [2007] found allelic variations in the 
FADS2 gene, which indicate that individuals differ in their genetic ability to 
metabolise Polyunsaturated Fatty Acids (PUFA) and this polymorphism has been 
proposed as the reason why PUFA supplementation studies obtain mixed results 
[Janssen & Kiliaan, 2014]. And, at least in animal models, the mRNA expression of 
FADS2 is higher in the liver of females suggesting an enhanced ability of females to 
process fatty acids [Sibbons et al., 2014].  
In a supplementation study, a higher level of DHA supplementation significantly 
improved the mean cognitive development of girls, but no such effect was seen in 
boys [Makrides, 2013]. It has been suggested that future studies looking at the 
associations between ASD and LCPUFA deficiency need to control for gender 
[Lohner et al., 2013].  
A breastmilk compositional study has shown that in primates, the milk composition 
for male offspring can differ to the milk for female offspring with a higher level of 
fats versus sugar [Hinde, 2007]. Perhaps male offspring require higher levels of 
LCPUFAs due to a decreased ability to metabolise fatty acids.  
In this study, the age of the mother was a significant predictor of ASD diagnosis, but 
the age of the father was not. Not only do older mothers have a higher likelihood of 
birth interventions [Carolan et al., 2011], but if they do indeed have depleted fatty 
acid stores, it would be worthwhile prioritizing older mothers as a cohort for 
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LCPUFA status assessment and supplementation if needed.  
In this study, higher maternal education was significantly predictive of ASD diagnosis. 
Breastfeeding rates in older mothers are contradictory in the literature [Scott & Binns, 
1998], however there is a consistent relationship between a higher educational level 
and a greater likelihood of optimal breastfeeding occurring [Scott & Binns, 1998; 
Ladomenou et al., 2007], which was supported in this study.  
This study has a number of limitations. Firstly, it relied on a non-biological measure 
of fatty acid deficiency, the seven clinical signs of FAD. Although this measure of 
fatty acid status has been used in other studies [Stevens, Zentall, & Deck, 1995; Bell 
et al., 2004; Antalis et al., 2006; Sinn, 2007] and correlated with plasma fatty acid 
levels, it would be highly preferable to measure fatty acid status biologically.  
Secondly, the collection of data on birth histories was through self-report, which may 
be susceptible to recall bias. However, while self-report and recall studies are less 
reliable than direct collection of data, it has been shown that self-report correlates 
with hospital records [Sou et al., 2006]. Nonetheless, it would be more optimal to gain 
access directly to hospital records or maternal health nurse records, even if just to 
confirm the self-report findings.  
Whilst this study shows correlational effects between breastfeeding factors, fatty acid 
status and ASD, longitudinal studies are needed to corroborate the potential for 
causative effects of breastfeeding duration on both the fatty acids and ASD diagnosis.  
This study did not take into account the fatty acid status of the mothers. In the 
Western world, we are becoming more deficient in n-3 fatty acids such as ALA and 
DHA [Gibson et al., 2011]. A baby breastfed in the 1980s would have had access to 
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higher levels of DHA via breastmilk than a baby today [Gibson et al., 2011] due to 
their mother’s higher levels of LCPUFAs. A study by Xie and Innis [2008] found that 
mothers that show genetic variance in the FADS2 gene have lower fatty acids in their 
mammary gland and breastmilk, which may indicate that altered fatty acid 
metabolism in the mother has an impact on the infant’s supply of LCPUFAs.  
The strengths of this study were a large, heterogeneous sample that had good 
representation of hospital and home births and thorough coverage of known risk 
factors for ASD diagnosis. The large sample size and comprehensive coverage of 
prognostic factors allowed for adequate control of confounding, providing a clearer 
representation of pertinent risk factors for ASD. Additionally, the cluster-adjusted 
path analysis used to document the association between ASD diagnosis and known 
risk factors allowed us to account for the biological and environmental effects of 
being in the same family.  
Future directions  
It is envisaged that the significant relationship between breastfeeding duration and 
fatty acid deficiency found in this study may encourage future research to consider 
breastfeeding factors as an important factor implicated in ASD risk. As Caspi et al. 
[2007] stated; genome wide scans that look for direct effects of the phenotype 
regardless of environmental influences, will miss those genetic effects that are 
conditional upon the effects of the environment. The link that was previously found 
between genetic variation on the FADS2 gene and resultant IQ could have only been 
found against the background of breastfeeding that was “universal before formula 
feeding” [Caspi et al., 2007, p. 18863].  
In regard to formula feeding, around the world, infant formulas are modelled on the 
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composition of breast milk of women in the U.S: that is, high in levels of n-6 LA with 
low amounts of n-3 LCPUFAs such as DHA [Gibson et al., 2011]. This is not 
indicative of LCPUFA levels in the breastmilk of women from other cultures [Huang 
et al., 2013], nor is it an ideal level in general. It is simply reflective of the 
degradation of the Western diet over time in regard to LCPUFAs. More research is 
needed to determine optimal and safe levels of LCPUFAs in all artificial milk 
substitutes when breastmilk is unavailable directly from the infant’s mother or from a 
human milk bank. Further investigation is warranted into differentiating LCPUFA 
levels in infant formulas for male and female infants.  
Further investigation and validation of the fatty acid deficiency scale (FAD) is 
reasonable and if it continues to show itself to be a reliable measure of fatty acid 
deficiency, it may prove to be a first line, non-invasive observable biomarker that 
assist health professionals to be alert to the potential consequences of fatty acid 
deficiency in both infants and adults (especially pregnant women), and signal a need 
for supplementation.  
In addition to providing a source of pre-formed LCPUFAs, human milk profoundly 
affects the function and integrity of the gastrointestinal tract [Colome et al., 2007], 
which is known to have both immunological and neurological functions [de Theije et 
al., 2014]. Human milk is a highly complex bioactive substance that delivers 
nutritional, health and protective benefits to an individual in ways that are currently 
not well understood [Hinde & German, 2012] and the breastfeeding period may be a 
critical window to set down developmental pathways [Hinde & German, 2012]. More 
precise and detailed breastfeeding research is required in order to more fully 
understand the unique bioactive substance that is human milk and how it interacts and 
alters in response to the human it is feeding.  
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The findings in this study indicate that the duration of breastfeeding may have the 
potential to alter the fatty acid status of infants. With the addition of breastfeeding 
factors in the model, this study found that some risk factors such as low birth weight 
and pre-term birth that are commonly associated with an elevated ASD risk became 
non-significant when family and breastfeeding variables were accounted for. The 
results of this study indicate that the continuation of breastfeeding may have a 
protective role in ASD via the provision of essential fatty acids at a critical time in an 
infant’s development.  
Abbreviations: 
 
Autism Spectrum Disorder, ASD, Fatty Acids, Fatty Acid Deficiency, FAD, Long-
chain Polyunsaturated Fatty Acids, LCPUFA, FADS2, Artificial Rupture of 
Membranes, AROM, mRNA, DHA, PUFA, MPLUS, NICU, LA, ALA, EFA, EPA, 
DPA  
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Chapter 7: Discussion 



This body of research investigated the potential associations between breastfeeding 
and fatty acid deficiencies in Autism Spectrum Disorder (ASD) and the mediational 
role of fatty acid deficiency in the relationship between breastfeeding duration and 
ASD diagnosis. 
 
The first published paper of this thesis titled, ‘Fatty acids, breastfeeding and autism 
spectrum disorder’ (Brown and Austin, 2009), focussed on the role of colostrum in 
ASD and theorised that breastfeeding within the first hour of life, as per World Health 
Organisation (WHO) guidelines, may have a protective function in ASD. The paper 
discussed the placental transfer of LCPUFAs, the role of colostrum in animal 
management and suggested the research practice of making a theoretical separation 
between colostral feeding and mature milk feeding.  
 
The second paper of this thesis titled, ‘Autistic disorder and phospholipids: A review’ 
(Brown and Austin, 2011), suggested that dysregulated fatty acid metabolism may 
function in ASD the way it had been theorised to function in schizophrenia by 
Horrobin (1998). Evidence was gathered to synthesise the membrane hypothesis of 
schizophrenia by Horrobin (1998) with the evidence for a ‘membrane hypothesis of 
ASD’.  The paper found evidence to support the notion that dysregulated fatty acid 
metabolism could be an underlying causative agent in both schizophrenia and ASD. It 
called for more research into ASD that accounted for colostral intake and 
breastfeeding. This paper has since been cited in several peer reviewed journal articles 
Autism Spectrum Disorder, Essential Fatty Acids and Infant Feeding 


EB

(Kroll, 2013; Pecorelli, 2013; Hong, 2014; Ciccoli, 2013; Al-Farsi, 2012, Liu, 2011, 
Chen, 2013) and Al-Farsi et al  (2012) referenced and researched some of the 
questions posed in the review paper. With a modest sample size, Al-Farsi et al (2012) 
found that first hour breastfeeding and breastfeeding duration was significantly 
associated with a diagnosis of ASD. To account for colostral intake, Al-Farsi (2012) 
tested the associated between breastfeeding delay and ASD, which was subsequently 
found to be non-significant after adjusting for other pertinent prognostic factors. The 
breastfeeding delay variable was included in the larger study to ascertain whether a 
larger and more heterogeneous sample would reveal any effect however, the non-
significant result was consistent.  
 
The third paper of this thesis titled, Observable essential fatty acid deficiency markers 
and autism spectrum disorder (Brown, Austin & Busija, 2014), was inspired by the 
findings of Stevens (1995) and Bell (2004) that deficiencies in EFAs were observable 
by behavioural and physiological signs: brittle nails, dry hair and skin, dandruff, 
rough skin, excessive thirst and frequent urination. Although the measure has 
limitations (Sinn, 2006), the fatty acid deficiency (FAD) signs showed such a strong 
significant association with ASD in the pilot paper, that it was used again in the fourth 
and final paper of this thesis. After accounting for shared family environment, first 
hour breastfeeding and the FAD score showed a highly significant relationship with a 
diagnosis of ASD.  In this study (Brown, Austin & Busija, 2014), gender did not 
reach significance in the relationship with ASD diagnosis, however with the larger 
sample size of the last paper (Brown, Busija, Shandley & Austin, 2015), male gender 
was significantly associated with ASD diagnosis.  
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As an addendum, this research for the third paper was conducted over the phone with 
mothers (and one father) of children with an ASD diagnosis. The incredible 
challenges faced by parents with a child suffering from a condition with no known 
cause or cure, highlighted the importance of the continued research effort to 
understand ASD.  
 
The fourth and final paper of this thesis titled, ‘Staying the Course: Breastfeeding 
duration as a protective factor in ASD and fatty acid deficiency’ (Brown, Busija, 
Shandley & Austin, 2015), investigated the relationship between birth interventions 
and ASD, with breastfeeding duration as a potential protective factor in ASD and a 
mediating effect of fatty acid status. The results showed a significant association 
between breastfeeding duration and ASD, and the mediating effect of fatty acid status 
was supported. Birth interventions such as inductions, epidurals and caesareans were 
found to be significantly correlated with a reduction in the duration of breastfeeding. 
This study utilised a large and heterogeneous sample and a sophisticated statistical 
approach and provides evidence for the protective role of optimal breastfeeding in 
ASD. It also supports the notion that neonatal risk factors and birth intervention risk 
factors for ASD such as low birthweight and caesareans may be viewed as disruptors 
of optimal breastfeeding, rather than risk factors in isolation.  
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Implications of research 
 
Breastmilk and breastfeeding 
The research presented in this thesis supports the continued investigation into 
breastmilk composition and function. The calls to action in breastfeeding research 
have been summarised as follows (Neville et al., 2012): 
1. The urgent need to define the precise interaction and function of human and 
other milks. 
2. Infant nutrition and breastfeeding to be viewed as an entire process from pre-
conception to post-natal life. 
3. High-risk populations given priority when measuring the impact of 
breastfeeding.  
In the context of this research, it could be argued that the call to action to prioritise 
high-risk populations could be as simple as focussing on the impact of breastfeeding 
on infant males. Considering the huge variation in ASD diagnoses between the sexes, 
it is warranted to focus research on LCPUFA status and the potential impact of 
breastfeeding in that specific cohort.  
 
Gender 

Males are over-represented in ASD populations by about 4:1 (Abrahams & 
Geschwind, 2008) and this pattern was replicated in this research also. Baron-Cohen 
has theorised that ASD is an artefact of an extreme male brain: neurocircuitry that 
systematises rather than empathises (Baron-cohen, 2002). It may well be very useful 
to codify ASD as a product of extreme ‘maleness’. Perhaps the utility of viewing 
metabolic systems such as the fatty acid metabolic pathways as more likely to be 
dysregulated in males will assist future research. Particularly, research is warranted 
into whether FADS2 gene variance is more likely to be found in males. The discovery 
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that primate milk is comprised of different elements depending on the sex of the 
infant and that the milk for sons of primiparous mothers are richer in fats than sugars 
and proteins (Hinde, 2007), may suggest a compensatory mechanism for fatty acid 
systems that are ‘known’ not to function as optimally in male infants.  
 
Colostrum 
One data paper in this research found a significant relationship between first hour 
breastfeeding and ASD and another found a significant relationship between first hour 
breastfeeding and breastfeeding duration, which was in turn associated with ASD. 
There may well be an advantage to studying the effect of colostrum separately in 
humans as it is in animal research. Animal studies consistently recommend colostral 
feeding and show that health outcomes are optimised with immediate colostral 
feeding. In animals, Lecce and Morgan (1962) found that the cessation of the 
absorption of macromolecules (gut closure) in the gut of the newborn animal was a 
function of the feeding regimen. Specifically, the piglet is born with an immature 
intestinal epithelium and the colostral milk of the sow provides proteins that 
contribute to the serum protein profile and factors that induce the closure of the gut 
(Lecce, Morgan, Matrone, & Carolina, 1964). This process is described as “delicate 
and synchronous” by Lecce and Morgan (1964, p. 47), as by the time the neonate has 
absorbed sufficient protein, the epithelial cell is mature and cannot absorb 
macromolecules any longer. This process is estimated to be approximately 86 hours in 
pigs and 32 hours in calves (Vukavic, 1984). In puppies, the intestinal barrier remains 
open for the first 12 hours after birth, but with a sharp decrease in absorption after 
four hours (Chastant-Maillard et al., 2012). Can we infer from these findings in 
animals that a similar process takes place in humans and if so, can this explain some 
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of the gastrointestinal issues found in some children with ASD (Russo & Andrews, 
2010)?  
 
Animal studies emphasise the role of colostral feeding in immuno-development also. 
For foals, the recommended timing of colostral feeding is within 12 hours as the 
amount of the immune factor IgG significantly reduces when colostrum is delayed 
(Raidal, McTaggart, & Penhale, 2005). In calves, research shows that passive 
immunity is achieved best with immediate colostral feeding, but that colostral feeding 
also enhances clinical, metabolic and endrocrine traits (Hadorn & Hammon, 1997). 
For puppies, the optimization of passive immune transfer requires that maternal 
suckling be given very early after birth (Chastant-Maillard, 2012). 
 
It is important to further research in humans what is already well established in animal 
studies. In the animal literature, colostrum seems to be synonymous with immunity 
rather than nutrition. Once again, it may be more theoretically sound to envisage 
colostrum as an important ingredient of passive immunity and gut closure, rather than 
as a source of nutrition in the infant. In fact, colostrum has been described as the 
“most potent natural immune booster known to science” (Uruakpa, Ismond, & 
Akobundu, 2002). In the first three days after birth, a human infant fed colostrum will 
consume as much IgA as is produced in the mucosa of an adult (Uruakpa, 2003). 
What are the consequences if this does not occur? Further, if there is a critical window 
of colostral feeding, what if any, is the effect of an infant not being supplied with 
colostrum in that critical period?  
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Limitations 

Self-report  
 
The research reported in this thesis was subject to a number of limitations. Firstly, the 
reliance on self-report for breastfeeding histories, health outcomes and diagnosis is 
potentially problematic. Hospital records are considered the gold standard (Sou et al, 
2006) and it would be optimal for studies to utilise the data collected at the time of 
birth. Nevertheless, research has shown that the correlation between medical records 
and maternal recall for specific outcomes such as birth weight and gestational age is 
around 0.9 and obstetric complications of sufficient severity, such as caesareans, are 
reliable (Sou et al, 2006).  
 
Biological measures 
Secondly, a biological measure of fatty acid deficiency in the infants and the mothers, 
would lend considerable veracity to the findings. Also, with no measure of the fatty 
acid status of the mothers, it is difficult to ascertain the effect of maternal LCPUFA 
levels on the fatty acid status of their infants. With the discovery that polymorphism 
in the FADS2 gene can affect both LCPUFA uptake, metabolism (Caspi, 2006) and 
milk production (Xie and Innis, 2008), these studies are hampered by their inability to 
gauge the influence of this seemingly important genetic variance.  
 
Gender 
The studies listed in this discussion have raised the question of gender differences in 
LCPUFA status, but these differences have not been addressed it statistically in this 
thesis. There is growing evidence that gender influences fatty acid metabolism and 
fatty acid levels in adults. A systematic review of 51 publications by Lohner, Fekete, 
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Marosvolgyi, and Decsi (2013) found such differences in the fatty acid profiles of 
men and women that they have called for LCPUFA studies to control for gender.  It 
remains to be seen whether the apparent differences in LCPUFA metabolism will 
influence further research into LCPUFA deficiencies and health outcomes.  
Challenges 

Birth cohort 
Breastfeeding research is a complex area due to birth cohort effects. In the following, 
research is presented that isolates at least three different cohorts in regard to 
breastfeeding:  
 
Breast-fed versus formula fed: Makrides et al (1994) conducted a study that compared 
the retinal and cortical levels of DHA in breast-fed infants when compared to 
formula-fed infants. Post-mortem studies on infants found that cortex DHA in formula 
fed infants did not increase with age (7% total fatty acids) whereas breastfed infant 
levels continued to increase (10% total fatty acids) until 48 weeks. They found that 
the length of breastfeeding was the major factor influencing the proportion of cortex 
DHA in infants.  
 
Breastfed versus breastfed: Gibson et al (2011) have noted that the breastmilk that a 
breastfed child in 2010 will receive will have a different nutritional profile than the 
breastfed child did in the 1980s due to falling levels of n-3 LCPUFAs in the Western 
diet. This also raises the challenge of comparing breastfed children who are brought 
up by mothers consuming a typical Western diet, versus breastfed infants from 
different cultural backgrounds. A study by of Taiwanese women found DHA levels in 
their breastmilk of 98% of the total fats in the breastmilk (Huang, 2013). These results 
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were even higher than those found in a cross-cultural review which showed DHA 
between ranges between 0.32 +/- 22% (Brenna et al., 2007).  
 
Breastfed versus formula fed (supplemented differently): Around the world infant 
formulas are modelled on the high LA and low LCPUFA levels found in mothers who 
eat a Western diet (Gibson, 2011). As research discovers more about the components 
of breastmilk, the artificial milk formulas change. For example, whey-dominant 
formulas appeared in the 1970s, in the 2000s the protein profile changed. In 1913, 
formula contained cod liver oil, then added calcium and now sn-2 palmitate is a focus 
(Sidnell & Greenstreet, 2011)  
 
Another consideration is dietary practices of the time. The practice of giving formula 
fed babies cod liver oil mixed with orange juice in the 1970s, just may have prevented 
some serious LCPUFA deficiencies from emerging at that time (Minchin, 2009). With 
the Western diet becoming more and more LCPUFA deficient, some of the older 
approaches to diet may have provided a protective effect that masked the deficiencies 
that researchers are finding now.  
 
Future directions  
 
Further research is needed into the significance of a common pattern of events 
referred to in ASD research. If being male makes an infant susceptible, perhaps due to 
less efficient fatty acid metabolism or a FAD2 genetic variation, then if that male 
infant does not receive any first hour colostrum, will they be immunologically 
compromised? If then they are not breastfed for long or at all, could they be more 
prone to ear infections? Some research suggests that breastfeeding has an inverse 
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relationship with ear infections (Ladomenou, Moschandreas, Kafatos, Tselentis, & 
Galanakis, 2010). Due to ear infections, will an infant be more exposed to antibiotics? 
Adams, Johansen, Powell, Quig, and Rubin (2011) showed an increase in ear 
infections and antibiotic use in individuals with ASD. Would a greater use of 
antibiotics affect the infant’s microbiome? Reports of high antibiotic exposure and GI 
dysfunction in the ASD population has encouraged research into disruption of the 
microbiome in ASD with particular attention paid to propionic acid (MacFabe, 2012). 
Will ear infections and immune dysfunction lead to more medication being given to a 
child? And could medications commonly used to reduce fever be associated with 
ASD (Becker & Schultz, 2010)? Will a dysfunctional microbiome and higher 
exposure to medication further compromise the infant’s ability to deal with 
environmental toxins? Will an infant develop ASD in response to a chain of risk? 
 
A number of studies, including Dietert and Dietert (2008), have investigated the 
possibility of early life immune insults that begin the chain of risk for an infant, but 
they rarely start with the breastfeeding status of the infant. As Caspi et al. (2007) 
explain in their study, breastfeeding can be viewed as the evolutionary background 
against which some effects are measured. Without the evolutionary backdrop, genetic 
variations that depend on environment will be missed (Caspi, 2007). This research 
indicates that breastfeeding needs to be at least considered as a factor by more 
researchers in study development.  
 
Further research is required to determine if there is a chain of risk in regard to the 
development of ASD. To conclude, the wider implications of the findings in this 
research are discussed.   
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Breastfeeding support for mothers 
 
A U.S. study (Bonuck et al., 2014) found that pre- and post-natal support, provided as 
a routine intervention to mothers, increased breastfeeding intensity and duration by 
more than 80% at three months. These very positive effects were gained by a lactation 
consultant with an average time investment of three hours per mother. Bonuck et al 
(2014) estimate that their intervention could be delivered to more than 600 mother-
infant dyads per year. The health benefits and cost savings in these types of 
intervention warrant further investigation. A key finding was that the intervention 
worked particularly well as it was delivered routinely to all mothers and not just to the 
mothers that actively sought help with breastfeeding. Further research is warranted 
into how many millions could be saved in health care with a fully resourced lactation 
consultancy provided routinely and governmental investment into a paid maternity 
leave scheme that would allow women the opportunity to breastfeed within WHO 
guidelines.   
 
Maternal screening for fatty acid deficiencies and potentially for the FADS2 gene 
implicated in hindering the conversion of EFAs into LCPUFAs could be used a 
diagnostic biomarker for ASD risk and early dietary intervention in both the mother 
and the neonate. Recently Bell et al. (2013) were investigating the possibility of a 
rapid whole blood finger tip analysis to analyse LCPUFA composition. This is a 
promising development for use in maternal and neonate screening and for those who 
already have a diagnosis of ASD. 
 


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Health professionals  
 
More research is warranted into the investigation of the observable signs of fatty acid 
deficiency. While they have been reported to not been a useful screening tool for 
those that may benefit from supplementation (Sinn, 2007), there is still scope to 
investigate the signs as a potential early warning sign for LCPUFA metabolism 
dysregulation or dietary deficiency. If the fatty acid signs can be validated into an 
empirically recognisable scale, there is the potential for clinicians and maternal health 
practitioners to have a non-invasive screening tool and an awareness of what the 
seemingly benign symptomatology may be indicating.  

Conclusions 

It is envisaged that research will continue into the relationship between breastfeeding, 
fatty acid status and ASD. This research supports the inclusion of comprehensive 
breastfeeding measures in the design of studies. Whilst acknowledging the limitations 
of this body of research, there are implications that fatty acid deficiency may be 
linked with breastfeeding duration and that birth interventions may be associated with 
ASD via disruption to the initiation and continuance of breastfeeding.  
 
For low-risk women in childbirth, the introduction of an epidural, augmentation of 
labour or induction contributes to an increase in the use of forceps, episiotomies and 
emergency caesareans (Tracy & Tracy, 2003). This is often described as the ‘cascade 
of interventions’ in childbirth. To be considered is whether this cascade of 
intervention in labour and childbirth, through its effect on breastfeeding initiation and 
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maintenance, contributes to a reduced availability of LCPUFAs and thus exposes the 
infant to other environmental or phenotypical consequences.  
 
The findings in this paper suggest a chain effect of risk in regard to an ASD diagnosis. 
That is, birth interventions or low birthweight or prematurity may disrupt the ability 
of a mother to feed her infant within the first hour of birth which may leave an infant 
immunologically exposed, and if the breastfeeding duration that follows is of a short 
duration, deficient in fatty acids. This may not be a causative pathway, but could 
conceivably contribute to the risk profile of an infant in regard to other environmental 
insults. 
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